Delivery Order SPE2DB20D3303-SPE2DB25FA0ED
- Not listed
- The Defense Logistics Agency awarded a $19,472.23 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Sprycel 50 mg, a pharmaceutical product used in cancer treatment. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of May 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement needs,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 30 tablets of Sprycel 100 mg, a targeted cancer therapy medication, with a ceiling value of $17,467.68. The contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a firm fixed-price procurement. This delivery order is classified as a child contract, indicating it was issued under a larger umbrella agreement. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $9,653.81 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a delivery order valued at $38,472.49 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packages) under a firm fixed-price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-competitive delivery order against an existing contract vehicle. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $16,591.33 delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be executed from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $16,333.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Sprycel 50 mg, a targeted cancer therapy medication. The contract was competitively awarded without set-asides and is scheduled for completion by September 17, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which...
- The Defense Logistics Agency awarded a delivery order valued at $13,143.67 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing under a delivery order contract type and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The...
- The Defense Logistics Agency awarded a $5,665.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,964.90 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,013.24 on July 25, 2025, for the supply of Sprycel 100 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and specifies a completion date of July 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0EDDelivery Order
The Defense Logistics Agency awarded a $9.6K delivery order to AmerisourceBergen Drug Corp for 60 tablets of Sprycel 70 mg, a targeted cancer therapy medication. This competitively awarded, firm fixed-price delivery order was issued on June 12, 2025, with an ultimate completion date of June 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under a larger indefinite delivery contract vehicle. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems and the Defense Health Agency. The parent IDC enables the company to deliver specialty medications, brand-name and generic drugs, and other medical commodities to support military operations and healthcare programs globally, with this particular order fulfilling pharmaceutical requirements for the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 6/12/25 |